Investegate |Karolinska Development AB (pub Announcements | Karolinska Development AB (pub: Karolinska Development's portfolio company Aprea Therapeutics announces that FDA has issued a clinical hold on lymphoid malignancy program

Investegate announcements from Karolinska Development AB (pub, Karolinska Development's portfolio company Aprea Therapeutics announces that FDA has issued a clinical hold on lymphoid malignancy program

Related Keywords

Sweden ,Stockholm ,Karolinska Institutet ,Johan Dighed ,Viktor Drvota ,Drug Administration ,Karolinska Development Ab Nasdaq Stockholm ,Karolinska Development ,Aprea Therapeutics ,Nasdaq Stockholm ,General Counsel ,Investegate Announcements ,Investegate Company Announcements ,Karolinska Development Ab Pub ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,ஸ்வீடந் ,ஸ்டாக்‌ஹோல்ம் ,ஏப்ரல் சிகிச்சை ,நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் ,ஜநரல் ஆலோசனை ,